129 related articles for article (PubMed ID: 12201723)
1. Total synthesis of luminacin D.
Shotwell JB; Krygowski ES; Hines J; Koh B; Huntsman EW; Choi HW; Schneekloth JS; Wood JL; Crews CM
Org Lett; 2002 Sep; 4(18):3087-9. PubMed ID: 12201723
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of luminacin D.
Jogireddy R; Maier ME
J Org Chem; 2006 Sep; 71(18):6999-7006. PubMed ID: 16930055
[TBL] [Abstract][Full Text] [Related]
3. Luminacins: a family of capillary tube formation inhibitors from Streptomyces sp. II. Biological activities.
Wakabayashi T; Kageyama-Kawase R; Naruse N; Funahashi Y; Yoshimatsu K
J Antibiot (Tokyo); 2000 Jun; 53(6):591-6. PubMed ID: 10966074
[TBL] [Abstract][Full Text] [Related]
4. Total Synthesis of (-)-Luminacin D.
Malassis J; Bartlett N; Hands K; Selby MD; Linclau B
J Org Chem; 2016 May; 81(9):3818-37. PubMed ID: 27054953
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric total synthesis of (-)-azaspirene, a novel angiogenesis inhibitor.
Hayashi Y; Shoji M; Yamaguchi J; Sato K; Yamaguchi S; Mukaiyama T; Sakai K; Asami Y; Kakeya H; Osada H
J Am Chem Soc; 2002 Oct; 124(41):12078-9. PubMed ID: 12371831
[TBL] [Abstract][Full Text] [Related]
6. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation.
Shim JS; Kim DH; Jung HJ; Kim JH; Lim D; Lee SK; Kim KW; Ahn JW; Yoo JS; Rho JR; Shin J; Kwon HJ
Bioorg Med Chem; 2002 Sep; 10(9):2987-92. PubMed ID: 12110321
[TBL] [Abstract][Full Text] [Related]
7. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation.
Shim JS; Kim DH; Jung HJ; Kim JH; Lim D; Lee SK; Kim KW; Ahn JW; Yoo JS; Rho JR; Shin J; Kwon HJ
Bioorg Med Chem; 2002 Aug; 10(8):2439-44. PubMed ID: 12057633
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer Effect of Luminacin, a Marine Microbial Extract, in Head and Neck Squamous Cell Carcinoma Progression via Autophagic Cell Death.
Shin YS; Cha HY; Lee BS; Kang SU; Hwang HS; Kwon HC; Kim CH; Choi EC
Cancer Res Treat; 2016 Apr; 48(2):738-52. PubMed ID: 26511816
[TBL] [Abstract][Full Text] [Related]
9. Stereocontrol by quaternary centres: a stereoselective synthesis of (-)-luminacin D.
Bartlett N; Gross L; Péron F; Asby DJ; Selby MD; Tavassoli A; Linclau B
Chemistry; 2014 Mar; 20(12):3306-10. PubMed ID: 24519660
[TBL] [Abstract][Full Text] [Related]
10. A study on the synthesis of antiangiogenic (+)-coronarin A and congeners from (+)-sclareolide.
Oh S; Jeong IH; Shin WS; Lee S
Bioorg Med Chem Lett; 2003 Jun; 13(12):2009-12. PubMed ID: 12781184
[TBL] [Abstract][Full Text] [Related]
11. Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
Ma L; Chen J; Wang X; Liang X; Luo Y; Zhu W; Wang T; Peng M; Li S; Jie S; Peng A; Wei Y; Chen L
J Med Chem; 2011 Oct; 54(19):6469-81. PubMed ID: 21853991
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human endothelial cells.
Ogita H; Isobe Y; Takaku H; Sekine R; Goto Y; Misawa S; Hayashi H
Bioorg Med Chem; 2002 Nov; 10(11):3473-80. PubMed ID: 12213461
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships studies of the anti-angiogenic activities of linomide.
Shi J; Xiao Z; Ihnat MA; Kamat C; Pandit B; Hu Z; Li PK
Bioorg Med Chem Lett; 2003 Mar; 13(6):1187-9. PubMed ID: 12643940
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of angiogenesis inhibitors: aromatic enone and dienone analogues of curcumin.
Robinson TP; Ehlers T; Hubbard IV RB; Bai X; Arbiser JL; Goldsmith DJ; Bowen JP
Bioorg Med Chem Lett; 2003 Jan; 13(1):115-7. PubMed ID: 12467629
[TBL] [Abstract][Full Text] [Related]
15. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Zhou G; Tsai CW; Liu JO
J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor.
Schmidt JM; Tremblay GB; Pagé M; Mercure J; Feher M; Dunn-Dufault R; Peter MG; Redden PR
J Med Chem; 2003 Apr; 46(8):1289-92. PubMed ID: 12672229
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities.
Ahn CM; Shin WS; Bum Woo H; Lee S; Lee HW
Bioorg Med Chem Lett; 2004 Aug; 14(15):3893-6. PubMed ID: 15225692
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics.
Fraley ME; Rubino RS; Hoffman WF; Hambaugh SR; Arrington KL; Hungate RW; Bilodeau MT; Tebben AJ; Rutledge RZ; Kendall RL; McFall RC; Huckle WR; Coll KE; Thomas KA
Bioorg Med Chem Lett; 2002 Dec; 12(24):3537-41. PubMed ID: 12443771
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.
Oh S; Jeong IH; Ahn CM; Shin WS; Lee S
Bioorg Med Chem; 2004 Jul; 12(14):3783-90. PubMed ID: 15210144
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol.
Jeong BS; Choi NS; Ahn SK; Bae H; Kim HS; Kim D
Bioorg Med Chem Lett; 2005 Aug; 15(15):3580-3. PubMed ID: 15978809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
